EUVIMEDTutustu EUVIMEDiin
LeserbriefOpen access · CC BY 4.0

Mobile apps in dermatology: Bridging innovation and care

Simona A Alomary iD, Elyse Mackenzie, Samavia Khan iD, Babar K Rao

Skin Research and Technology · 2024

DOI: 10.1111/srt.13640 ↗

At a glance

Leserbrief in Skin Research and Technology, 2024. Written by Simona A Alomary and 3 co-authors. Institution: Department of Dermatology, Rutgers New Jersey Medical School, Newark, New Jersey, USA. Major MEDLINE topics: Mobile Applications, Dermatology, Telemedicine. Cited 4 times so far (Crossref); 4 references. The full text is freely available (open access, CC BY 4.0).

TiivistelmäSubjectsBibliografiset tiedotCiteRelated studies

Abstract (original language)

Dermatological drug development has experienced a booming influx over the past decade, providing novel solutions for a diverse array of skin conditions.1 This growth is attributed to both advancements in biological therapeutics and a heightened understanding of treatment options amongst providers and patients. While the advent of novel pharmacological targets holds potential for improved patient outcomes, dermatologists face the challenge of staying abreast of drug developments while delivering effective clinical care.2 In response, mobile applications have emerged in hopes of bridging the gap between innovations and clinical practice.3 While over 50 000 mobile health (mHealth) apps were available on the Apple App store in 2022, it is unclear how many of these applications can guide providers in dermatological medication management.4 This paper investigates the ability of top-rated mobile iOS dermatological applications to incorporate new drug development data into their use as clinical support tools. We ultimately stress the need for development of a comprehensive drug-centric dermatological app for the betterment of providers, patients, and the wider healthcare system. A recent US-based review identified a total of 632 mobile health (mHealth) applications on Android and Apple devices that are specific to dermatology.1 The review further categorized applications by intended use. The majority of identified applications fell into the category of "disease guide," with 163 apps (25.8%) focusing on including etiology, pathogenesis, and treatment of specific skin diseases. Other categories included "self-surveillance/diagnosis," "teledermatology," "general dermatology reference," "educational aid," and more. Of these applications, 395 (62.5%) were marketed towards patients, 203 (32.1%) were marketed towards providers, and 34 (5.4%) were marketed towards both. Authors Oullette and Rao summarize characteristics of top dermatological apps based on the number of reviews per category. However, this summary does not specify whether these apps provide dermatological drug-specific guidance for healthcare professionals. We investigated whether the top provider-facing iOS applications in each category had the capability to provide updated information about new drugs, treatment guidelines, and/or drug-related research findings (Table 1). It is worth mentioning that Oullette and Rao specifically focused on analyzing the top-reviewed apps in each category, with the intention of capturing the mobile tools most frequently utilized by providers. Future studies could consider conducting a more comprehensive scoping review of all 632 dermatological apps that are currently available. Of the 632 applications identified in the previous study, only 17 (2.68%) were provider-facing, placed within the top five most reviewed applications for each category, and available on iOS.1 Of these 17 applications, we identified 4 that included information about treatment options for dermatological conditions: "VisualDx", "iDoc Academy", "TopDerm", and "HumazeMD". This accounts for

Subjects

MeSH terms (MEDLINE)

Mobile ApplicationsDermatologyTelemedicineHumans

Authors and institutions

  • Department of Dermatology, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
  • Department of Dermatology, Rutgers Robert Wood Johnson Medical School, Piscataway, New Jersey, USA.

ORCID profiles: Simona A Alomary, Samavia Khan

Cite

APA

Alomary, S. A., Mackenzie, E., Khan, S., & Rao, B. K. (2024). Mobile apps in dermatology: Bridging innovation and care. Skin Research and Technology. https://doi.org/10.1111/srt.13640

Vancouver

Alomary SA, Mackenzie E, Khan S, Rao BK. Mobile apps in dermatology: Bridging innovation and care. Skin Research and Technology. 2024. doi:10.1111/srt.13640

BibTeX
@article{Alomary2024,
  author = {Alomary, Simona A and Mackenzie, Elyse and Khan, Samavia and Rao, Babar K},
  title = {Mobile apps in dermatology: Bridging innovation and care},
  journal = {Skin Research and Technology},
  year = {2024},
  doi = {10.1111/srt.13640}
}
Start for free →